These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

8692 related articles for article (PubMed ID: 19277228)

  • 1. Quality of evidence about effectiveness of treatments for metastatic uveal melanoma.
    Augsburger JJ; Corrêa ZM; Shaikh AH
    Trans Am Ophthalmol Soc; 2008; 106():128-35; discussion 135-7. PubMed ID: 19277228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of treatments for metastatic uveal melanoma.
    Augsburger JJ; Corrêa ZM; Shaikh AH
    Am J Ophthalmol; 2009 Jul; 148(1):119-27. PubMed ID: 19375060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent breakthroughs in metastatic uveal melanoma: a cause for optimism?
    Sacco JJ; Kalirai H; Kenyani J; Figueiredo CR; Coulson JM; Coupland SE
    Future Oncol; 2018 Jun; 14(14):1335-1338. PubMed ID: 29741103
    [No Abstract]   [Full Text] [Related]  

  • 4. Survival Rates in Patients After Treatment for Metastasis From Uveal Melanoma.
    Lane AM; Kim IK; Gragoudas ES
    JAMA Ophthalmol; 2018 Sep; 136(9):981-986. PubMed ID: 29955797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Invited commentary. Uveal melanoma: implications of tumor doubling time.
    O'Brien J
    Ophthalmology; 2001 May; 108(5):831-2. PubMed ID: 11780648
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of uveal melanoma metastatic to the liver: a review of the M. D. Anderson Cancer Center experience and prognostic factors.
    Bedikian AY; Legha SS; Mavligit G; Carrasco CH; Khorana S; Plager C; Papadopoulos N; Benjamin RS
    Cancer; 1995 Nov; 76(9):1665-70. PubMed ID: 8635073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delayed systemic recurrence of uveal melanoma.
    Kolandjian NA; Wei C; Patel SP; Richard JL; Dett T; Papadopoulos NE; Bedikian AY
    Am J Clin Oncol; 2013 Oct; 36(5):443-9. PubMed ID: 22706174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor doubling times in metastatic malignant melanoma of the uvea: tumor progression before and after treatment.
    Eskelin S; Pyrhönen S; Summanen P; Hahka-Kemppinen M; Kivelä T
    Ophthalmology; 2000 Aug; 107(8):1443-9. PubMed ID: 10919885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival in patients with presymptomatic diagnosis of metastatic uveal melanoma.
    Kim IK; Lane AM; Gragoudas ES
    Arch Ophthalmol; 2010 Jul; 128(7):871-5. PubMed ID: 20625048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of liver metastases from uveal melanoma: a retrospective single-center analysis.
    Yang XY; Xie F; Tao R; Li AJ; Wu MC
    Hepatobiliary Pancreat Dis Int; 2013 Dec; 12(6):602-6. PubMed ID: 24322745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uveal melanoma: implications of tumor doubling time.
    Singh AD
    Ophthalmology; 2001 May; 108(5):829-31. PubMed ID: 11319992
    [No Abstract]   [Full Text] [Related]  

  • 12. Uveal melanoma: a rare malignancy.
    Gragoudas ES; Egan KM
    Ophthalmology; 2000 Aug; 107(8):1441-2. PubMed ID: 10919884
    [No Abstract]   [Full Text] [Related]  

  • 13. Survival of patients with metastases from uveal melanoma.
    Gragoudas ES; Egan KM; Seddon JM; Glynn RJ; Walsh SM; Finn SM; Munzenrider JE; Spar MD
    Ophthalmology; 1991 Mar; 98(3):383-9; discussion 390. PubMed ID: 2023760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term progression-free survival in metastatic uveal melanoma after chemoimmunotherapy and consolidation thermoablation.
    Al-Jamal RT; Eskelin S; Pyrhönen S; Kivelä T
    Acta Oncol; 2009; 48(3):476-9. PubMed ID: 19031163
    [No Abstract]   [Full Text] [Related]  

  • 15. [Therapy of metastatic malignant uveal melanoma].
    Jäckel A; Bock M; Deichmann M; Waldmann V; Näher H
    Hautarzt; 2001 Feb; 52(2):98-103. PubMed ID: 11244899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A pilot study of intrahepatic yttrium-90 microsphere radioembolization in combination with intravenous cisplatin for uveal melanoma liver-only metastases.
    Arulananda S; Parakh S; Palmer J; Goodwin M; Andrews MC; Cebon J
    Cancer Rep (Hoboken); 2019 Aug; 2(4):e1183. PubMed ID: 32721131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overall survival after treatment for metastatic uveal melanoma: a systematic review and meta-analysis.
    Rantala ES; Hernberg M; Kivelä TT
    Melanoma Res; 2019 Dec; 29(6):561-568. PubMed ID: 30664106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Update on Metastatic Uveal Melanoma: Progress and Challenges.
    Spagnolo F; Picasso V; Spano L; Tanda E; Venzano C; Queirolo P
    BioDrugs; 2016 Jun; 30(3):161-72. PubMed ID: 27000042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long overall survival after dendritic cell vaccination in metastatic uveal melanoma patients.
    Bol KF; Mensink HW; Aarntzen EH; Schreibelt G; Keunen JE; Coulie PG; de Klein A; Punt CJ; Paridaens D; Figdor CG; de Vries IJ
    Am J Ophthalmol; 2014 Nov; 158(5):939-47. PubMed ID: 25038326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic Ultrasonography for Surveillance in Patients With Uveal Melanoma.
    Choudhary MM; Gupta A; Bena J; Emch T; Singh AD
    JAMA Ophthalmol; 2016 Feb; 134(2):174-80. PubMed ID: 26633182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 435.